© 2024 Blaze Media LLC. All rights reserved.
FDA issues warning to cannabis companies for unsubstantiated claims its products fight cancer
November 20, 2017
The U.S. Food and Drug Administration put several cannabis companies on notice for marketing marijuana-derived products that claim to treat diseases like cancer. According to a report published on the FDA's website Nov. 1, the administration issued warnings to four companies: Greenroads Health, Natural Alchemist, That’s Natural! Marketing and Consulting, and Stanley Brothers Social Enterprises LLC.
Here are the contested claims as listed on the FDA's website:
- “Combats tumor and cancer cells;”
- “CBD makes cancer cells commit ‘suicide’ without killing other cells;”
- “CBD … [has] anti-proliferative properties that inhibit cell division and growth in certain types of cancer, not allowing the tumor to grow;” and
- “Non-psychoactive cannabinoids like CBD (cannabidiol) may be effective in treating tumors from cancer – including breast cancer.”
On this episode of "Chewing the Fat" with Jeffy, Pat, Keith, and Jeffy discussed the FDA's decision to crackdown on businesses including one that listed "love" as an ingredient in their products.
To see more from Pat, visit his channel on TheBlaze and listen live to “Pat Gray Unleashed” with Pat Gray weekdays 12 p.m. – 3 p.m. ET, only on TheBlaze Radio Network.
Want to leave a tip?
We answer to you. Help keep our content free of advertisers and big tech censorship by leaving a tip today.
Want to join the conversation?
Already a subscriber?
News, opinion, and entertainment for people who love the American way of life.
BlazeTV
BlazeTV Staff
News, opinion, and entertainment for people who love the American way of life.
@BlazeTV →more stories
Sign up for the Blaze newsletter
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.
© 2024 Blaze Media LLC. All rights reserved.
Get the stories that matter most delivered directly to your inbox.
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.